secwatch.observer — SEC 8-K summary
======================================

Issuer:     Genprex, Inc. (GNPX)
CIK:        0001595248
Form:       8-K
Filed at:   2026-07-30T20:31:02+00:00
Accession:  0001437749-26-025074
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Genprex receives Nasdaq exception to continue listing; must meet $1 bid price by July 29, 2026
--------------------------------------------------------------------------------

- Nasdaq panel granted exception to continue listing; must demonstrate $1.00 minimum bid price compliance by July 29, 2026 and maintain through Dec 7, 2026.
- Company implemented 1-for-22 reverse stock split on July 16, 2026 to help regain compliance with bid price requirement.
- Panel retains jurisdiction until Dec 7, 2026; failure to maintain compliance could lead to delisting.
- New Nasdaq rule effective July 22, 2026 allows immediate suspension if market value of listed securities falls below $5M for 30 consecutive days.
- No assurance of maintaining compliance; delisting could harm capital raising, stock price, and business development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595248/000143774926025074/0001437749-26-025074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595248/000143774926025074/gnpx20260730_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-025074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer